Antithrombotic and thrombolytic therapy in acute cardiac care

Crit Care Clin. 2001 Apr;17(2):379-90, vii. doi: 10.1016/s0749-0704(05)70173-1.

Abstract

This article explores the use of antithrombotic and thrombolytic therapy in acute cardiac care, and looks at traditional anticoagulant agents, newer antithrombin agents, thrombolytic agents, and others.

Publication types

  • Review

MeSH terms

  • Anticoagulants / therapeutic use*
  • Coronary Disease / drug therapy*
  • Coronary Disease / prevention & control
  • Fibrinolytic Agents / therapeutic use
  • Heparin / analogs & derivatives*
  • Heparin / therapeutic use
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Myocardial Infarction / drug therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Thrombin / antagonists & inhibitors

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Platelet Aggregation Inhibitors
  • ITF 300
  • Heparin
  • Thrombin